NICTAVI, means blink in Latin. We are a Blue Ocean niche value-driven ophthalmic medical device startup.
FDA Registration #3017733452
We are a B2B wholesale company, selling our products to eye care professionals, clinicians, hospital chains, the Military, Over-the-Counter, and possibly to Pharma, through distributors, Group Purchasing Organizations, and our online store.
PURCHASING: For clinicians and resellers that wish to gain access to the Nictavi Shop for purchasing, Please email email@example.com and request the link and password. Thank you.
We accept all major credit cards.
Our mission is to preserve sight, reduce suffering, and improve people’s quality of life.
Our first product, the patented, novel, Tarsus Eyelid Patch, is a comfortable, effective method of eyelid closure.
Eyelid closure has been proven to retain moisture, reduce the occurrence and heal epithelial or corneal surface defects, and enhance the effectiveness of eye medicines. This reducing doctor visits, surgeries, pain, irritation, and the chance of infections.
Soon to be the patient's and doctor's choice for a more comfortable, manageable, therapeutic eyelid closure treatment option.
The Tarsus Eyelid Patch is a more patient compliant method of therapeutic eyelid closure that will transform cornea care. With a leap of value it will replace antiquated, uncomfortable, eyelid closure devices and techniques for addressing applicable eye health issues. Using unique design, simple mechanics, and the most advanced materials and adhesives, the Tarsus Eyelid Patch represents a significant improvement in effectiveness and patient comfort in eyelid closure.
The Tarsus Patch is a device that allows for adding medicine or artificial tears periodically while being worn, or during surgery. The closure stiffness is such that eye drops can be administered to the eye by simply pulling the lower lid down with a finger and applying the drops to the eye without disturbing the position of the patch on the upper tarsus or eyelid. Upon the release of the lower eyelid, the eye is closed again as the upper eyelid is held in the closed position by the applied Tarsus Patch. This reduces or eliminates corneal damage due to a lack of tear production, exposure keratopathy, or drying of the cornea.
Corneal defects occur in 20–42% of ICU patients due to exposure from insufficient eyelid closure, and 60% of those sedated for 48 hours.
There are currently NO COMFORTABLE, effective products designed for the corneal care, eyelid closure / occlusion, and ocular therapeutics markets. There is a need for a comfortable eye closure device and method to address Nocturnal Lagophthalmos. Our product can be worn during sleep to address Noctural Lagophthalmos (the cause) and prevent corneal defects or damage, (the symptoms). Nocturnal Lagophthalmos is the inability to close the eyelids during sleep, or insufficient eyelid closure during sleep. It may reduce the quality of sleep, cause exposure-related symptoms or, if severe, cause corneal damage (exposure keratopathy). The degree of Lagophthalmos can be minor (obscure Lagophthalmos), or quite obvious. Lagophthalmos - Wikipedia https://en.wikipedia.org › wiki › Lagophthalmos
To heal severe conditions doctors have long been performing a surgical procedure called a Tarsorrhaphy, in which the eyelids are partially sewn together. Our Tarsus Patch is a less extreme and painless method of eye closure that allows the patient or caregiver to maintain the closure therapy as needed or prescribed.
In some cases partial eyelid closure is desired. This can be achieved with the Tarsus Patch by positioning at application. Application positioning is key in all cases. The wearer needs to find the application positioning or sweet spot for their individual orbital eye socket anatomy and the desired amount of eyelid closure desired.
Due to lower lid anatomy or various lower lid functionality issues it may be necessary to support the lower lid to achieve effective eyelid closure.
The Tarsus Patch works more by design on people with mid to deep eyes with non-hooded eyelids, but with all of the diversity of the eyelid and brows it is expected that people will adapt wearing it in a manner that suits them best, and our patch is easy to reposition.
Our Tarsus Eyelid Patch was created from the patient / customer's perspective, and it is the guiding principle of our entire business model.
Ask for the Tarsus Eyelid Patch by Nictavi from your doctors, hospitals, pharmacies, GPOs and medical device distributors. Thank you.
(See: Building Business Models on Customer Insights in the Business Model Generation by Alexander Osterealder & Yves Pigner.)
Nictavi is a registered Trademark. SN #88446381. We are a Limited Liability Company.
NICTAVI LLC, FDA CDRH Registration and Listing
FDA Registration Number: 3017733452
FDA Owner Operator Number: 10079434
Liability Insurance Coverage with Llyod’s of London CFC Underwriting Limited
POLICY NUMBER: BSJ0028878530
THE INSURED: Nictavi LLC